Info

IDEXX Pharmaceuticals, Inc., is focused on the development, registration and marketing of novel therapeutics for the animal health market. The company currently markets ACAREXX otic suspension, a one-dose ear mite treatment for cats, and Facilitator liquid bandage for the treatment of wounds on dogs, cats and horses. In 2001, IPI introduced the new SNAP® Foal IgG Test, which measures immunoglobulin levels in newborn foals. IDEXX Pharmaceuticals also has a number of products in the registration process with the FDA, including a nitazoxanide-based product for treatment of equine protozoal myeloencephalitis-a neurological disease that is believed to affect approximately 200,000 horses in the US; a topical nonsteroidal anti-inflammatory for equine use; an insulin product for the treatment of diabetic cats; and a long-acting injectable antibiotic for cats are also in development.